Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2057 of 6351
-
Magnetic brain zaps could lift depression in seniors without pills
Symptom relief CompletedMajor depressive disorder (MDD) is a common psychiatric condition, mostly treated with antidepressant drugs, which are limited for issues such as refractoriness, adverse effects and drug interactions, especially in the elderly population. In this context, the investigators invest…
Sponsor: University of Sao Paulo • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC
-
Can a precise radiation burst stall Cancer's spread?
Disease control OngoingThe purpose of this study is determine if receiving stereotactic body radiation(SBRT) when participants' metastatic tumors have just begun to grow increase the length of time before disease gets worse
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New MRI scan could predict kidney cancer aggressiveness without a biopsy
Diagnosis OngoingThis feasibility study will evaluate how well hyperpolarized 13C pyruvate magnetic resonance imaging (MRI) scan works in predicting tumor aggressiveness in participants with renal tumors. Hyperpolarized 13C pyruvate is a non-radioactive substance with potential usage in the diagn…
Phase 2 • Sponsor: Zhen Wang, MD • Aim: Diagnosis
Last updated Jun 27, 2026 09:07 UTC
-
New dressing may keep amputation wounds clean and closed
Prevention CompletedThis study is a prospective, multi-center, two-arm, unblinded, and randomized controlled trial with a goal of evaluating the impact of a closed incision negative pressure dressing (PREVENA) on incidence of post-operative wound complications and medical costs in patients undergoin…
Sponsor: Thomas Jefferson University • Aim: Prevention
Last updated Jun 27, 2026 12:00 UTC
-
New genetic sleuthing could solve mysterious fetal swelling cases
Diagnosis CompletedBrief Summary: Nonimmune hydrops fetalis (NIHF) is a potentially fatal condition characterized by abnormal fluid accumulation in two or more fetal compartments. Numerous etiologies may lead to NIHF, and the underlying cause often remains unclear (1). The current standard of genet…
Sponsor: Thomas Jefferson University • Aim: Diagnosis
Last updated Jul 16, 2026 00:00 UTC
-
New CAR T-Cell therapy targets Hard-to-Treat multiple myeloma
Disease control OngoingThe body has different ways of fighting infection and disease. No single way seems perfect for fighting cancer. This research study combines two different ways of fighting disease: antibodies and T cells. Antibodies are proteins that protect the body from disease caused by bacter…
Phase 1 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 26, 2026 18:33 UTC
-
Blood test could steer cancer treatment to right drug
Disease control Recruiting nowThis multicenter study, randomized, controlled of blood-based biomarker-driven targhet therapy. Patients were selectedm( at Hospital San Giovanni and Celio in Rome) according to CTCs results ( CTCs-guided managment performed at University Magna Graecia) or managed by the treating…
Phase 2 • Sponsor: Matteo's Friends • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New hope for HIV nerve pain: Drug-Free relief on the horizon?
Symptom relief CompletedDistal sensory peripheral neuropathy (DSP) is a chronic, debilitating painful condition affecting quality of life in persons living with HIV. Treatments prescribed to manage DSP pain, such as nonnarcotic and narcotic analgesics, antidepressants and anticonvulsants, are largely in…
Sponsor: New York University • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
Immunotherapy-Chemo combo targets tough neuroendocrine cancers
Disease control OngoingThis phase Ib trial studies how well pembrolizumab works with combination chemotherapy in treating participants with small cell/neuroendocrine cancers of the urothelium or prostate that has spread to nearby tissue or lymph nodes or that has spread to other places in the body. Mon…
Phase 1 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Could a simple leg cuff cut stroke risk? new study tests EECP therapy
Disease control CompletedIntracranial stenosis is prevalent among Asians and constitute a common cause of cerebral ischemia. While the best medical therapy carries stroke recurrence rates in access of 10% per year, intracranial stenting was associated with unacceptable peri-procedural ischemic events. Ce…
Sponsor: National University of Singapore • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
Dancing away arthritis: could tango boost daily activity?
Symptom relief CompletedThe hypothesis is that pleasure brought by argentine tango practice would increase total physical activity of patients with chronic inflammatory arthritis.
Sponsor: University Hospital, Clermont-Ferrand • Aim: Symptom relief
Last updated Aug 05, 2026 00:00 UTC
-
Gentle tai chi may get spondyloarthritis patients moving
Symptom relief CompletedOur hypothesis is that tai chi sessions would increase physical activity of patients with Spondyloarthitis. The main objective is to study the effect of tai chi sessions (16 vs.0) on global physical activity of Spondyloarthitis patients, compared to a control group without tai ch…
Sponsor: University Hospital, Clermont-Ferrand • Aim: Symptom relief
Last updated Aug 09, 2026 00:00 UTC
-
New cocktail of drugs and radiation aims to boost stomach cancer treatment before surgery
Disease control OngoingThis pilot phase I/II trial studies the side effects and how well nivolumab and ipilimumab in combination with chemotherapy and radiation therapy work in treating patients with gastric cancer that can be removed by surgery. Immunotherapy with monoclonal antibodies, such as nivolu…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Immunotherapy boosts standard treatment for aggressive cervical cancer
Disease control CompletedThis phase I trial studies how well atezolizumab before and/or with standard of care chemoradiotherapy works in immune system activation in patients with stage IB2, II, IIIB, or IVA cervical cancer that has spread to the lymph nodes. Immunotherapy with monoclonal antibodies, such…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Can a heart registry unlock the secrets of broken heart syndrome?
Knowledge-focused Recruiting nowThe Cedars-Sinai SHI Takotsubo Registry and Proteomic Study is an observational registry that will collect retrospective and prospective demographic, clinical, hemodynamic, laboratory and other diagnostic parameters, therapy and outcome data from individuals who meet the inclusio…
Sponsor: Cedars-Sinai Medical Center • Aim: Knowledge-focused
Last updated Aug 21, 2026 00:00 UTC
-
New radiation device aims to cut breast cancer treatment time
Symptom relief Recruiting nowThis study is a prospective, single arm study (registry) summarizing patient-level adverse-event and tumor outcomes as well as a number of feasibility and dosimetric characteristics of delivering a single-fraction boost with the GammaPod.
Sponsor: University of Maryland, Baltimore • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC
-
New hope for hearing loss? drug targets inner ear inflammation
Disease control Recruiting nowA Phase II randomized, placebo controlled study design of anakinra (Kineret) in corticosteroid-resistant or intolerant Meniere's disease (CR-MD)and corticosteroid-resistant or intolerant autoimmune inner ear disease (CR-AIED) patients. Patients will be randomized by a 2:1 allocat…
Phase 2 • Sponsor: Northwell Health • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Could a new PET scan help match pancreatic cancer patients to the right therapy?
Diagnosis CompletedCurrently there is no clinical biomarker that can be used to select patients for CCR2-targeted therapy and to monitor response to such therapy. Considering the toxicity and the rate of response to CCR2-targeted therapy, it is crucial to be able to identify patients who may not re…
Phase 1 • Sponsor: Washington University School of Medicine • Aim: Diagnosis
Last updated Jun 27, 2026 12:30 UTC
-
Could a vaccine made from your own cells help control HIV?
Disease control CompletedThis study will be done in people living with HIV to see if an investigational vaccine made from a person's own white blood cells is safe and tolerated. This study will also look at the body's immune response to the vaccine and evaluate four different methods of making the vaccin…
Phase 1 • Sponsor: Sharon Riddler • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Skin clues could unmask rare nerve disease in kids
Knowledge-focused Recruiting now.Neurofibromatosis type 2 is an inherently autosomal dominant genetic disease, but cases of mosaicism or de novo mutation are not uncommon. the prevalence is estimated at 1 / 60,000. the clinical presentation is based on the appearance of tumors in the central and peripheral nerv…
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC